Ghent University Academic Bibliography

Your filters: cql: author="Chalmers, James D." or (type any "bookEditor issueEditor" and editor="Chalmers, James D.")

Add to list
Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

James D. Chalmers, Pierre-Régis Burgel, Charles L. Daley, Anthony De Soyza, Charles S. Haworth, David Mauger, Michael R. Loebinger, Pamela J. McShane, Felix C. Ringshausen, Francesco Blasi, et al.

(2025) NEW ENGLAND JOURNAL OF MEDICINE. 392(16). p.1569-1581
Add to list
- Miscellaneous
Understanding the clinical implications of the 'non-classical' microbiome in chronic lung disease : a viewpoint

Steven L. Taylor, Aurélie Crabbé (UGent) , Luke R. Hoffman, James D. Chalmers and Geraint B. Rogers

(2024) EUROPEAN RESPIRATORY JOURNAL. 63(2).
Add to list
- Journal Article
- A1
- open access
Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro.

Ellen Goeteyn, Steven L. Taylor, Alison Dicker, Laura Bollé (UGent) , Merel Wauters (UGent) , Marie Joossens (UGent) , Eva Van Braeckel (UGent) , Jodie L. Simpson, Lucy Burr, James D. Chalmers, et al.

(2024) RESPIRATORY RESEARCH. 25(1).
Add to list
- Journal Article
- A1
- open access
Objective sputum colour assessment and clinical outcomes in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)

Stefano Aliberti, Felix C. Ringshausen, Raja Dhar, Charles S. Haworth, Michael R. Loebinger, Katerina Dimakou, Megan L. Crichton, Anthony De Soyza, Montse Vendrell, Pierre-Regis Burgel, et al.

(2024) EUROPEAN RESPIRATORY JOURNAL. 63(4).

Academic Bibliography

Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

Understanding the clinical implications of the 'non-classical' microbiome in chronic lung disease : a viewpoint

Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro.

Objective sputum colour assessment and clinical outcomes in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)

Contents

Support

Contact